Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

about

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

Item

http://www.wikidata.org/entity/Q52659267

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

@en

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

@nl

type

Item

label

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

@en

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

@nl

prefLabel

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

@en

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

@nl

P1476

Clinically feasible stratification of 1-year to 3-year post-myocardial infarction risk.

@en

P2093

Donald L Lappé

http://www.w3.org/2001/XMLSchema#string

Durgesh Bhandary

http://www.w3.org/2001/XMLSchema#string

Greta L Hoetzer

http://www.w3.org/2001/XMLSchema#string

Joseph B Muhlestein

http://www.w3.org/2001/XMLSchema#string

Naeem D Khan

http://www.w3.org/2001/XMLSchema#string

Tami L Bair

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

A prediction rule to identify low-risk patients with community-acquired pneumonia

Validation of Clinical Classification Schemes for Predicting Stroke

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart

Repeated measurement of the intermountain risk score enhances prognostication for mortality.

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality.

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

P304

e000723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/OPENHRT-2017-000723

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin D Horne

P577

2018-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29531761

http://www.w3.org/2001/XMLSchema#string

P932

5845421

http://www.w3.org/2001/XMLSchema#string